Skip to main content
OpenTrials

Clinical trial condition

Exocrine Pancreatic Insufficiency

Explore clinical trials studying Exocrine Pancreatic Insufficiency. Study availability and eligibility vary by location and protocol.

104 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Exocrine Pancreatic Insufficiency trial results

Completed

A Study of the Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

NCT00662675

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +12 more
Locations
  • Long Beach, California, United States
  • Los Angeles, California, United States
  • Orlando, Florida, United States
  • Louisville, Kentucky, United States
View Trial Details
Completed

Control of Steatorrhea in Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

NCT01327703

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +14 more
Locations
  • Klinikum-Bochum Bochum, Germany
  • Universitätsklinikum Carl Gustav Carus Dresden, Germany
  • Universitaetsklinikum Erlangen Erlangen, Germany
  • Jena University Hospital, Universitaetsklinikum Jena Jena, Germany
View all 13 locations
View Trial Details
Completed

A Study to Evaluate the Mode of Administration and Safety of EUR-1008 (APT-1008) in Infants 1 to 12 Months of Age

NCT01100606

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +6 more
Locations
  • Nemours Children's Clinic Jacksonville, Florida, United States
  • Children's Lung Specialists Ltd. Las Vegas, Nevada, United States
  • Akron Children's Hospital Akron, Ohio, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details
Completed

Safety and Efficacy Study of 2 Pancreatic Enzymes for Treatment of Exocrine Pancreatic Insufficiency in Cystic Fibrosis.

NCT01641393

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cystic Fibrosis, Digestive System Diseases, +7 more
Locations
  • University Hospital Antwerp - Universitair Ziekenhuis Antwerpen (UZA) Antwerp, Belgium
  • Universitair Ziekenhuis Gent, Centrum voor Mucoviscidose Ghent, Belgium
  • Clinic of Paediatric Diseases at UMHAT Dr Georgi Stranski Pleven, Bulgaria
  • Clinic of Genetic and Paediatric Diseases at UMHAT Sveti Georgi Plovdiv, Bulgaria
View all 37 locations
View Trial Details
Completed

A Randomized, Double-Blind, Dose Response-Control, Crossover Study to Evaluate the Safety and Efficacy of Two Doses of EUR-1008 (APT-1008) in Chronic Pancreatitis (CP) Participants With Exocrine Pancreatic Insufficiency (EPI)

NCT00788593

Conditions
Chronic Disease, Chronic Pancreatitis, Digestive System Diseases, +7 more
Locations
  • Woodland International Research Group Little Rock, Arkansas, United States
  • HealthCare Partners Medical Group Los Angeles, California, United States
  • University of Florida, General Clinical Research Center Gainesville, Florida, United States
  • Advanced Medical Research Center Port Orange, Florida, United States
View all 18 locations
View Trial Details
Completed

Creon 40,000 for Treatment of PEI (Pancreatic Exocrine Insufficiency) Due to Chronic Pancreatitis

NCT00705978

Conditions
Digestive System Diseases, Exocrine Pancreatic Insufficiency, Pancreatic Diseases, +1 more
Locations
  • Site Reference ID/Investigator# 45389 Bangalore, India
  • Site Reference ID/Investigator# 45396 Bhopal, India
  • Site Reference ID/Investigator# 45390 Chennai, India
  • Site Reference ID/Investigator# 45391 Hyderabad, India
View Trial Details
Completed

Creon After Pancreatic Surgery

NCT00535756

Conditions
Digestive System Diseases, Exocrine Pancreatic Insufficiency, Pancreatic Diseases, +1 more
Locations
  • Site Reference ID/Investigator# 45022 Rousse, Bulgaria
  • Site Reference ID/Investigator# 45020 Sofia, Bulgaria
  • Site Reference ID/Investigator# 45026 Greifswald, Germany
  • Site Reference ID/Investigator# 45025 Hamburg, Germany
View all 15 locations
View Trial Details

Related conditions